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Abstract
Background: Historically, the main focus of studies of childhood mortality has been the infant and under-five mortality
rates. Neonatal mortality (deaths ,28 days of age) has received limited attention, although such deaths account for about
41% of all child deaths. To better assess progress, we developed annual estimates for neonatal mortality rates (NMRs) and
neonatal deaths for 193 countries for the period 1990–2009 with forecasts into the future.
Methods and Findings: We compiled a database of mortality in neonates and children (,5 years) comprising 3,551 country-
years of information. Reliable civil registration data from 1990 to 2009 were available for 38 countries. A statistical model
was developed to estimate NMRs for the remaining 155 countries, 17 of which had no national data. Country consultation
was undertaken to identify data inputs and review estimates. In 2009, an estimated 3.3 million babies died in the first month
of life—compared with 4.6 million neonatal deaths in 1990—and more than half of all neonatal deaths occurred in five
countries of the world (44% of global livebirths): India 27.8% (19.6% of global livebirths), Nigeria 7.2% (4.5%), Pakistan 6.9%
(4.0%), China 6.4% (13.4%), and Democratic Republic of the Congo 4.6% (2.1%). Between 1990 and 2009, the global NMR
declined by 28% from 33.2 deaths per 1,000 livebirths to 23.9. The proportion of child deaths that are in the neonatal period
increased in all regions of the world, and globally is now 41%. While NMRs were halved in some regions of the world, Africa’s
NMR only dropped 17.6% (43.6 to 35.9).
Conclusions: Neonatal mortality has declined in all world regions. Progress has been slowest in the regions with high NMRs.
Global health programs need to address neonatal deaths more effectively if Millennium Development Goal 4 (two-thirds
reduction in child mortality) is to be achieved.
Please see later in the article for the Editors’ Summary.
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30Introduction
The first 4 wk of life—the neonatal period—carries one of the
highest risks of death of any 4-wk period in the human lifespan [1].
In high-income countries (HIC), neonates are now a major focus
of child health both for mortality and morbidity reduction.
However, in lower-income countries neonatal mortality rates
(NMRs), trends, and causes have attracted relatively little attention
compared to maternal deaths or deaths among older children
under 5 and in international public health policy and programmes,
neonatal deaths still do not receive attention commensurate with
their burden [2]. A specific focus on neonatal mortality is required
as the epidemiology, cause-of-death distribution, and health
interventions differ to older children. Child survival programmes
have typically focused on diseases affecting children aged over
1 mo—primarily pneumonia, malaria, diarrhoea, and vaccine-
preventable diseases—and safe motherhood programmes have
tended to focus on the mother and not her newborn [3].
The single most important factor behind increased attention for
neonatal deaths is Millennium Development Goal (MDG) 4,
which calls for a two-thirds reduction in mortality risks of children
under 5 y of age between 1990 and 2015, equivalent to an average
annual reduction of 4.4% [2]. The last few years have seen a
welcome acceleration in progress towards this goal, but less
attention has been paid to neonates and less progress made
compared to older children under the age of 5. Hence neonatal
deaths represent an increasing proportion of global under-five
deaths [4,5]. In 2005, The Lancet Neonatal Survival Series
highlighted the annual toll of 4 million neonatal deaths, provided
the first systematic estimates of neonatal deaths by cause [1],
identified 16 simple and extremely cost-effective interventions that
could reduce neonatal deaths by 67% [6], and proposed specific
actions in countries [7] and globally [8].
One key action to increase attention and guide action is the
availability of annual estimates by country of the NMR (the
probability of dying in the first 28 d of life) [8,9]; this remains a
gap. United Nations (UN) partners, led by the World Health
Organization (WHO), have produced maternal mortality ratio
(MMR) estimates every 5 y [10]. Each year the UN Inter-agency
Group for Child Mortality Estimation (IGME) produces national
estimates of infant mortality rate (IMR) and under-five mortality
rate (U5MR). The inputs, methodology, and determination of
uncertainty bounds for these estimates have been improved over
recent years (www.childinfo.org/mortality_igme.html). The sourc-
es of NMR data are very similar to those for under-five mortality
and available in the same countries and with the same frequency,
yet so far NMR estimates have not been part of this annual
process, and publication of neonatal mortality estimates has been
unpredictable in timing and used changing methods, which has
limited trend analysis and reduced policy attention. For example,
the recent 2010 Millennium Development Goals summit and
multiple associated progress reports barely mentioned neonatal
deaths [11].
During 2010, national and global estimates for both maternal
[12,13] and child mortality [14,15] were published by both the
UN and by the Institute of Health Metrics and Evaluation
(IHME). Considerable debate ensued around the various inputs,
methods, and estimates. IHME’s child mortality publication and
the associated media interest were primarily focused on under-five
mortality, and national and regional estimates of NMR and
neonatal deaths were provided for only 2 y, 1990 and 2010.
A recent series on global health estimates in PLoS [16] has
highlighted many of the debates in global estimation, and lessons
learned and proposed ways forward [17–21]. Given defects or
deficiencies in existing empirical NMR data, statistical estimation
will be necessary for most countries for the foreseeable future [18],
and a key message is that countries, academics, and UN agencies
have a role to play in improving the data and methods and in
ensuring transparency.
In this article we build on these lessons to develop an improved
modeling approach for national estimates of NMRs for the years
1990 to 2009 and for forecasts of future trends. Our work is linked
to a wider collaboration between UN agencies and academic
research groups to understand and estimate rates (www.childinfo.
org/mortality_igme.html) and causes of deaths in neonates and
children (Child Health Epidemiology Reference Group, www.
cherg.org) in order to inform public health policy. In addition, a
country consultation process was undertaken by WHO to
maximize identification of all input data and to allow countries
to review and provide feedback to estimates.
Methods
Ethics Statement
An ethics statement was not required for this work.
Data Identification and Inclusion
Data on neonatal mortality come from a variety of sources,
including civil registration systems and household surveys such as
Demographic and Health Surveys (DHS; www.measuredhs.com),
as well as special studies. Box 1 presents an overview of challenges
and limitations to data and neonatal mortality estimation.
We assessed all these different data sources and included those
meeting our inclusion criteria, that is, reporting population-based
data with neonatal deaths and under-five deaths with a
denominator of livebirths. Although under-reporting of neonatal
deaths is a concern even in middle- and high-income settings [22–
24], we did not adjust neonatal mortality data points for under-
reporting. To ensure consistency with U5MR estimates produced
for the UN by IGME and to account for variation in survey-to-
survey measurement errors, we rescaled U5MR and NMR data
points for all years to match the latest time series estimates of
U5MR produced by IGME [14]. On average, rescaled values
were 9.7% higher than original observation values, with 38% of
data points increasing in value, 18% decreasing, and the
remaining data points (all from civil registration) being unchanged.
This rescaling assumes that the proportionate difference in NMR
and U5MR is equal for each data point.
A country consultation was undertaken by WHO between
December 2010 and January 2011 to give the Ministry of Health in
each of the 193 countries the opportunity to review all data inputs
and NMR draft estimates for the years 1990, 2000, and 2009 for
their country. No countries had comments on the NMR estimates
themselves, but 18 countries provided a total of 19 additional data
points—allcivilregistrationdatapointsfortheyears2008and2009.
The final database and results presented in this paper incorporate
the additional data points from the country consultation process.
The final input database included 3,551 country-years with data
from 176 countries representing all WHO regions. Civil regis-
tration and surveillance system data provided 2,378 data points,
and household survey data 1,173 data points (of which 976 were
from DHS) (Figure 1). The empirical dataset (original and with
U5MRs and NMRs rescaled) can be found on the following Web
site (www.who.int/healthinfo/statistics/mortality/en/).
Countries were classified by their income level as assessed in
2010 by the World Bank (World Bank List of Economies, July
2010, http://go.worldbank.org/K2CKM78CC0). Estimates of
livebirths were taken from the World Population Prospects: The
Trends in Neonatal Mortality Levels 1990–2009
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on World Bank income-group and WHO region (Figure 2). Our
analyses and results are presented by WHO region for low- and
middle-income countries (LMICs), and separately for HICs.
Equatorial Guinea is an exception to this rule being the only
HIC in Africa. Given the similarity of Equatorial Guinea’s NMR
to those of other countries in Africa, Equatorial Guinea was
grouped with the other countries in the WHO Africa region.
NMR Estimation by Country
We used two methods to estimate country-specific NMRs, with
the choice of method depending on the data available for each
country. Figure 3 outlines which method was used for each
country. Method 1 was used for 38 countries (8% of global
livebirths in 2009), and method 2 for 155 countries (92% of global
livebirths in 2009).
Method 1. Civil registration data. For countries with high-
quality civil registration data covering at least 17 of the 20 y in the
period 1990–2009, and with no more than two consecutive years
without data, NMR estimates were taken directly from civil
registration systems and rescaled by the same proportion as the
IGME adjustment to U5MR as outlined above. Thus, we used the
empirical ratios of NMR to U5MR, but IGME adjusted U5MR
levels. High-quality civil registration was defined as follows: (a)
100% complete for adults [26] and (b) greater than 85% complete
for children when comparing under-five mortality estimates from
civil registration with estimates produced by IGME [14]. If there
were no empirical data for a given year, we used data from the
years closest to the year of estimate using the average of ratios of
NMR to U5MR for surrounding years, or if the year of estimate
was more recent than the year of data, the ratio of NMR to
U5MR from the most recent year with empirical data.
Method 2. Statistical model (Figure 3). For the remaining
countries, a multilevel statistical model was developed and used to
predict NMR. The statistical model selected was the best
performing model from a series of potential statistical models
evaluated by ten-fold cross-validation [27]. Cross-validation
involves splitting the dataset randomly into ten equally sized
subsets, and then for each of the subsets examining the prediction
errors obtained when fitting a model to the other nine subsets. To
minimize chance effects from splitting the dataset into subsets, ten-
fold cross-validation was carried out five times. Prediction
accuracy was assessed using two criteria: (a) the absolute
difference between observed and predicted NMRs, and (b) the
relative difference between observed and predicted NMRs. Text
S1 lists cross-validation results. On the basis of the evaluation of
model performance, only the most recent data point for each
survey was included—reducing the number of country-years of
observation from 3,551 to 2,648—and the final model was fitted to
data from 1990 onwards only—which further reduced the dataset
used to fit the final model from 2,648 to 1,388 observations. The
2007 study by Murray et al. [28] similarly concluded that inclusion
of only the most recent data point for each survey improved the
performance of their statistical model. It seems that the inclusion
of older data points for each survey is more likely to add additional
noise than additional useful information for the statistical
modeling. This effect is likely due to greater measurement
errors, and or greater recall or survival bias of data points
further back in time in retrospective surveys.
The final model was as follows:
ln NMRi=1,000 ðÞ ~a0zb1 ln U5MR=1,000 ðÞ zb2 
ln U5MR=1,000 ðÞ ½ 
2

zaji ½ zaki ½ zei,
where, for observation i, that is for each country-year of
observation, aj[i] and ak[i] are country-level and region-level
random effects, respectively, and ei is a random error term.
Figure 4 illustrates our modeled relationship between U5MR and
NMR as used to estimate NMR for method 2 countries. The
country-level random effect was assumed to be zero when
predicting for countries without country-specific input data
meeting our inclusion criteria. Other statistical models evaluated
included HIV/AIDS mortality rates and malaria prevalence as
predictors, as these had been used as predictors in previous
exercises conducted by WHO to estimate NMR [5].
Box 1. Challenges and Limitations to NMR
Estimation
NMRs are highest in countries and communities with the
least information on these deaths. This inverse relationship
naturally leads to uncertainties in global, regional, and
country estimates of NMRs.
The gold standard for mortality data collection is a high-
coverage, high-quality civil registration system. We assessed
that only 38 countries had a civil registration system of
sufficient population coverage, quality, and completion for
the period 1990–2009 to be used for neonatal mortality
estimation, and censuses have typically only collected data
that enable estimation of infant and under-five mortality
rates, or have not asked or reported specifically on neonatal
outcomes. Mortality data collection is often difficult in
countries with ongoing or recent civil conflict or disaster—
most often due to breakdown of collection systems or
because data collection risks compromising the security of
participants. In our study, the 17 countries that had no
relevant, recent data of any kind include countries that have
experienced recent civil unrest.
The most common data source globally for child and
neonatal mortality is retrospective household surveys such
as the DHS, which rely on birth histories and do report
neonatal outcomes. The neonatal period has historically
been granted little space and effort in data collection and
analyses. UNICEF’s Multiple Indicator Cluster Surveys (MICS)
are an increasing source of national estimates for under-five
mortality but usually rely on demographic indirect estima-
tion techniques that have been developed to estimate
mortality rates when exact information on times of births
and deaths of children is missing, and usually do not
provide estimates of NMRs. Some MICS have used birth
histories and have reported NMR (Malawi and several of the
central Asian Republics). If more MICS followed this lead
then data on neonatal deaths would increase markedly.
For retrospective birth histories and incomplete civil
registration systems, under-reporting of neonatal deaths
is believed to be a bigger problem than under-reporting of
deaths among older children. Neonatal deaths are less
likely to be recorded if the baby dies in the first few hours
or days after birth or is very small. Additionally, misclas-
sification of stillbirths and early neonatal deaths is likely to
occur [36]. There is an urgent need for research into the
extent and frequency of possible under-reporting of
neonatal deaths from retrospective surveys, ideally by
comparing such data with prospective data for the same
population within the same time period. Additionally
asking for a pregnancy history would theoretically be
superior to asking only for live births in terms of capture of
early neonatal deaths and stillbirths.
Trends in Neonatal Mortality Levels 1990–2009
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To generate estimates of uncertainty for method 2 countries, we
drew 1,000 bootstrap samples from the estimation dataset and
repeated the estimation steps for each sample. The new NMR
parameter estimates for each sample, including the estimate of the
country- and region-specific random effects, were used to generate
a new set of predictions. For countries not included in the
bootstrap sample, and, thus, without an estimate of the country-
specific random effect, we randomly generated a country-specific
effect using the estimated between-country standard deviation for
that country’s region derived from the bootstrap sample. For
Method 1 countries, we used the uncertainty range around U5MR
to generate uncertainty estimates for NMR. Here, ratios of upper
and lower uncertainty ranges of NMR to the NMR estimate were
assumed to be the same as for U5MR. To obtain global and
regional level estimates of uncertainty, we summed the data at
global or regional level for each bootstrap prediction run. We used
the 2.5th and 97.5th percentiles of the resulting distributions
around the estimates as uncertainty range.
Trend Analysis of Neonatal Mortality Levels
We analysed trends of neonatal mortality using two indicators,
the NMR and the absolute number of neonatal death. The two
indicators measure or convey complementary information. NMR
is an indication of the risk of neonatal death per livebirth, and as a
risk measure is comparable across time and countries. The
number of neonatal deaths depends on the NMR and the number
of livebirths and is a useful measure of burden when comparing
with other conditions. Both indicators are needed by public health
policy-makers and health programmes to understand the scope of
neonatal deaths in their country and, together with similar
information on levels and causes of morbidity and mortality for
other age groups, to prioritize public health interventions.
Regional and global NMRs can be interpreted as mortality risk
measures weighted by livebirths in individual countries. For
example, NMR levels and trends in the Western Pacific LMIC
region are largely driven by China, as the vast majority of annual
livebirths in this region are in China, and, similarly, trends and
levels in the Southeast Asia LMIC region are predominantly
driven by India. We estimated absolute numbers of neonatal
deaths using our estimated NMRs and livebirths for each country
from 1990 onwards. Regional and global deaths and NMRs were
also calculated. Forecasts for 2010 and onwards are based on
average annual changes in NMR over the period 1999–2009, and
assuming constant rates of change from 2009 onwards. To
adequately consider neonatal deaths due to the Rwanda genocide,
we assumed that 1/60 of the child deaths under five attributed to
the genocide, as estimated by IGME [14], occurred in the
neonatal period.
Results
Over the 20 y from 1990 to 2009, an estimated 79 million
babies died in the first 4 wk of life. Of these, the vast majority
(.98%) died in LMIC, with 31 million in Southeast Asian LMIC,
and 21 million in African LMIC. There were 1 million deaths in
HIC.
All regions of the world have seen reductions in NMR, but there
are major regional variations in the estimated rate of reduction.
Globally, the average NMR has fallen by more than a quarter over
20 y, from 33.2 to 23.9 per 1,000 livebirths, or an average of 1.7%
per year. The biggest percentage reductions in NMR have been in
European LMIC (down 49%), American LMIC (down 48%), and
Western Pacific LMIC (down 48%) (see Tables 1, S1, S2, S3, S4;
Figure S1, which have estimates and graphs for all countries and
Figure 1. Data sources used for NMR estimation. Year of most recent survey with neonatal and under-five mortality rates information is
indicated as greater or less than 5 y before 2008. Countries with no relevant, recent data of any kind are indicated as not available.
doi:10.1371/journal.pmed.1001080.g001
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regions). Southeast Asian LMIC had the highest NMR in 1990
(NMR=46.9) but only the third highest in 2009 (30.7) after
Eastern Mediterranean LMIC (31.1) and African LMIC (35.9).
The two latter regions have seen the smallest reductions in NMR
over the period, and are the only two regions with average annual
reductions in NMR of less than 2%. The Africa LMIC region saw
the smallest reduction in NMR, with a total reduction of only
17.6% (1.0% per year) between 1990 and 2009.
Over the period 1990–2009, regions fall into three broad
categories in terms of NMR level (Figure 5): HICs have much
lower NMR and fewer neonatal deaths compared to the rest of the
world, currently accounting for 1.4% of annual global neonatal
deaths. Yet these countries continue to see major relative
reductions in NMR, from 6.0 to 3.6 per 1,000 livebirths between
1990 and 2009—a 40% reduction, and greater than the global
average reduction. Among LMICs, there is a clear separation
between the higher NMR regions of Africa, Eastern Mediterra-
nean, and Southeast Asia (NMR range 30.7–35.9 in 2009) and the
lower NMR regions of Western Pacific, Europe, and the Americas
(NMR range 10.7–12.0 in 2009).
In 2009, an estimated 3.3 million babies died globally before
reaching the age of 28 d compared with an estimated 4.6 million
deaths in 1990 (Figure 5; Table 1), a reduction of 29% in annual
deaths. The proportion of neonatal deaths that occurs in African
LMIC is increasing. If trends from the 11-y period 1999–2009
continue, the African region will overtake Southeast Asian LMIC
in 2010 as the region with most neonatal deaths. This reflects the
slower annual reduction in NMR in Africa LMIC compared to
other regions of the world (Table 1), and that Africa LMIC has
seen a 39.2% increase in annual births between 1990 and 2009,
whereas annual births have decreased for most other regions of the
world (Table S4).
The proportion of child deaths that occur in the neonatal period
has increased in all regions of the world; globally the proportion
increased from 37% in 1990 to 41% in 2009 (Figure 5D). The
regions with the largest relative increase in neonatal mortality
compared to mortality in older children under five were European
LMIC (39% to 50%), Southeast Asian LMIC (42% to 53%), and
Western Pacific LMIC (44% to 54%).
Of the 40 countries with the highest NMRs in 2009 (see
Figure 6), only six are from outside the African continent
(Afghanistan, Pakistan, India, Bhutan, Myanmar, and Cambo-
dia). Among the 15 countries with the highest NMRs (all above
39), 12 were from the African region (Democratic Republic of the
Congo, Mali, Sierra Leone, Guinea-Bissau, Chad, Central
African Republic, Burundi, Angola, Mauritania, Mozambique,
Guinea, and Equatorial Guinea), and three were from the
Eastern Mediterranean (Afghanistan, Somalia, and Pakistan).
Throughout the period 1990–2009, India has been the country
with largest number of neonatal deaths. In 2009, the five
countries with most deaths accounted for more than half of all
neonatal deaths (1.7 million deaths=52%), and 44% of global
livebirths: India (27.8% of deaths, 19.6% of global livebirths),
Nigeria (7.2%, 4.5%), Pakistan (6.9%, 4.0%), China (6.4%,
13.4%), and Democratic Republic of the Congo (4.6%, 2.1%).
Region
HIC
Africa LMIC
Americas LMIC
Eastern Mediterranean LMIC
Europe LMIC
South-East Asia LMIC
Western Pacific LMIC
Not available
Not applicable
Figure 2. Geographical regions used in study. The map illustrates the geographical regions used both in the statistical model and when
summarizing results at regional level in the main text (Table S3 summarizes estimated neonatal mortality trends by MDG regions).
doi:10.1371/journal.pmed.1001080.g002
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1990 were: India (29.5% of deaths, 19.8% of global livebirths),
China (12.3%, 18.0%), Pakistan (5.4%, 3.4%), Bangladesh (5.0%,
2.9%), and Nigeria (4.8%, 3.3%). NMR estimates for each
country can be found in Table S1.
In eight countries NMRs are estimated to have increased over
the 20 y of study, and five of these countries are in Africa (Nauru,
Congo, Zimbabwe, Niue, Chad, Cameroon, Trinidad and
Tobago, and South Africa), and NMRs are unchanged over the
20 y for the Democratic Republic of Congo and Somalia. These
trends in NMRs between 1990 and 2009 are a result of U5MR
being estimated by IGME to have been increasing or been
constant over the period, respectively (Figure 7). Of the ten
countries with the greatest relative reductions in NMR (all saw
reductions of more than 68%), eight were HIC (San Marino,
Luxembourg, Czech Republic, Estonia, Cyprus, Singapore,
Greece, and Oman), one a Southeast Asian LMIC (Maldives),
and one a European LMIC (Serbia). When interpreting NMR
trends for countries with small numbers of annual livebirths the
low number of livebirths makes the estimation of an underlying
true population NMR less certain.
Discussion
This analysis is the first published set, to our knowledge, of
national annual time series for neonatal deaths for all the countries
of the world, involving country consultation, with forecasts, and
with a presentation and discussion of country and regional levels
and trends. The input database is extensive and the modeling
methods have been improved over previous exercises by UN
agencies [5], yet uncertainty remains wide and may not fully
capture remaining issues around underestimation and misclassifi-
cation of neonatal deaths and stillbirths. Because of the lack of
evidence and understanding of the frequency and extent of
possible under-reporting of neonatal deaths across data sources
(see Box 1), we have not attempted to adjust input data for possible
under-reporting, as is routinely done by many other global health
estimates [10]. Instead, we rescaled NMR and U5MR input data
to match U5MR estimates produced by IGME. This rescaling
assumes that the proportionate difference in NMR and U5MR is
equal for each data point. However, it is believed that under-
reporting of neonatal deaths is greater than for older children in
retrospective mortality data collection systems, especially house-
hold surveys which may ask about births in the previous 5 y (see
Box 1), which consequently would make our estimates of neonatal
deaths conservative.
As the risk of children dying before the age of five has fallen, the
proportion of child deaths that occur in the neonatal period has
increased. This increase is primarily a consequence of decreasing
non-neonatal mortality in children under five from infectious
diseases such as measles, pneumonia, diarrhea, malaria, and
AIDS. Globally, 41% of under-five deaths now occur in the
neonatal period. Over the 20 y between 1990 and 2009, the
proportion of global neonatal deaths that occurred in Africa
increased. Although Africa is now the region with the highest
NMR, the proportion of under-five child deaths that are neonatal
remains relatively low in Africa—the fraction increased from 26%
to 29% between 1990 and 2009. This apparent anomaly reflects
the fact that Africa accounts for approximately 90% of child
NMR estimation method
Civil registration
Statistical model
Not available
Not applicable
Figure 3. Methods used to estimate NMRs. The map illustrates the NMR estimation method used for each of the 193 countries estimated for.
doi:10.1371/journal.pmed.1001080.g003
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PLoS Medicine | www.plosmedicine.org 6 August 2011 | Volume 8 | Issue 8 | e1001080Figure 4. Modeled relationship between U5MR and NMR. The blue curve illustrates our fitted statistical model predicting NMR for method 2
countries (see Methods). The curve was drawn with country and regional random effects assumed zero to show the assumed functional relationship
between U5MR and NMR—in practice, within our multilevel statistical model, these random effects vary by country and region, respectively, such
that the precise functional relationship between NMR and U5MR differs between countries. The green curve is similar to the blue model without
allowing for a nonlinear association on the log scale. Compared to the green curve, the blue curve allows for more plausible changes in NMR at lower
levels of U5MR; particularly, the green curve implies impossible NMRs at small U5MRs for countries and regions with positive random effects, as NMR
would exceed U5MR. For comparison, the red line illustrates a linear relationship on the normal scale, NMR = U5MR, which is highly improbable, as it
would allow for the same change in NMR for a given change in U5MR at all levels of U5MR.
doi:10.1371/journal.pmed.1001080.g004
Table 1. Neonatal mortality trends in the period 1990–2009 globally and by WHO region (Table S3 summarizes the same trends by
MDG regions).
Region Neonatal Mortality 1990 1995 2000 2005 2009
Percent Change
1990–2009
(Annual)
Global NMR 33.2 32.0 29.4 26.3 23.9 228.0 (21.7)
Deaths in 1,000s (% of global) 4,574 (100) 4,296 (100) 3,913 (100) 3,536 (100) 3,265 (100) 228.6
HIC NMR 6.0 4.9 4.2 3.9 3.6 240.3 (22.7)
Deaths in 1,000s (% of global) 79 (1.7) 63 (1.5) 52 (1.3) 48 (1.4) 45 (1.4) 242.7
Africa (LMIC) NMR 43.6 43.0 41.1 38.3 35.9 217.6 (21.0)
Deaths in 1,000s (% of global) 971 (21.2) 1,047 (24.4) 1,094 (27.9) 1,119 (31.6) 1,114 (34.1) 14.7
Americas (LMIC) NMR 22.0 19.0 15.8 13.1 11.4 248.3 (23.4)
Deaths in 1,000s (% of global) 255 (5.6) 220 (5.1) 181 (4.6) 145 (4.1) 121 (3.7) 252.7
Eastern Mediterranean
(LMIC)
NMR 41.3 39.1 36.3 33.2 31.1 224.6 (21.5)
Deaths in 1,000s (% of global) 565 (12.4) 530 (12.3) 506 (12.9) 490 (13.9) 481 (14.7) 214.9
Europe (LMIC) NMR 21.0 20.1 17.0 13.2 10.7 249.2 (23.5)
Deaths in 1,000s (% of global) 148 (3.2) 118 (2.8) 90 (2.3) 72 (2.0) 60 (1.8) 259.6
South-East Asia (LMIC) NMR 46.9 43.6 39.2 34.2 30.7 234.6 (22.2)
Deaths in 1,000s (% of global) 1,860 (40.7) 1,738 (40.5) 1,549 (39.6) 1,326 (37.5) 1,161 (35.6) 237.6
Western Pacific (LMIC) NMR 22.9 22.1 18.6 14.6 12.0 247.5 (23.3)
Deaths in 1,000s (% of global) 694 (15.2) 580 (13.5) 442 (11.3) 336 (9.5) 283 (8.7) 259.3
doi:10.1371/journal.pmed.1001080.t001
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AIDS (0.2 million under-five deaths) [4], resulting in relatively
higher post-neonatal child mortality than other regions.
Globally, the average annual reduction in NMR appears to be
accelerating and was twice as high for the period 1999–2009
(2.3%) compared to that experienced in the period 1990–1999
(1.1%). Only HIC experienced lower average reduction in NMR
in the period 1999–2009 (1.7%) compared to that experienced in
the period 1990–1999 (3.7%), which may reflect the challenge of
reducing mortality in very preterm babies. However, while
progress appears to be increasing, the average annual rate of
NMR reduction is well below the MDG-4 goal (of 4.4%) at 1.7%
per year globally in the period 1990–2009, and less than for under-
five mortality at 2.1% per year in the same period [14] and
maternal mortality over the period 1990–2008 at 2.3% per year
[12].
If trends for NMR and U5MR from the period 1999–2009
continue, the risk of dying within the first 4 wk of life in Africa will
match the current risk in HIC by the year 2166 (Figure 8).
Although this forecast is simplistic as it assumes that the average
annual rate of reduction in Africa experienced between 1999 and
2009 will remain constant over the next 160 y in Africa (see
Figure 8), it highlights the very high current NMR levels in Africa
and the very slow progress in NMR reduction compared to other
regions of the world, particularly to HIC.
The trend and numbers in Western Pacific LMIC are
predominantly driven by China—e.g., in 2009, the proportions
of livebirths and neonatal deaths in the region that occurred in
China were 78% and 74%, respectively. In the period 1993–1998,
China appears to have experienced relatively large fluctuations in
the age distribution of child deaths aged less than five (Figure 5).
The Chinese Maternal and Child Health Surveillance System
(MCHSS) used in the neonatal mortality estimation makes use of
trained female health workers or village doctors to register child
births and deaths in villages and communities, and is believed to
be nationally representative and of relatively high quality [29].
However, we excluded data from MCHSS prior to 1999 because
of uncertainty about the quality of data [29], and used the
statistical model to predict NMRs for China for the whole time
period, 1990–2009. The number of non-neonatal deaths in
children under five decreased markedly in the period 1993–
1998, whereas the number of neonatal deaths was relatively
constant, as were both neonatal and under-five mortality rates.
The observed fluctuation in the age distribution of child deaths in
China between 1993 and 1998 appear to be predominantly driven
by changes in the population of children under five, as estimated
by the United Nations Population Division (see Figure S2), which
we used to estimate child deaths under five.
In our statistical model, the only predictor of NMR that can
change over time is U5MR. Our model allows for a nonlinear
NMR 2009
< 15
15 - 29
30 - 45
> 45
Not available
Not applicable
Figure 6. NMRs in 2009. The map illustrates the NMR in year 2009 for each of the 193 countries estimated for.
doi:10.1371/journal.pmed.1001080.g006
Figure 5. Regional trends in NMRs and numbers 1990–2009. (A) NMRs. (B) Neonatal deaths. (C) Percentage of global deaths per region. (D)
Percentage of child (under 5 y) deaths in neonatal period.
doi:10.1371/journal.pmed.1001080.g005
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for the ratio of NMR to U5MR to vary depending on U5MR,
country, and region (see Methods, Figure 4 in particular). The
Preliminary Report for the Malawi DHS 2010 survey was recently
released [30], and estimated a NMR of 31 for the 5-y period
2005–2010, that is with midpoint years 2007 and 2008. The
survey was not included in our input data used to develop our
statistical model, as it was not available at the time, but can be
used as a post hoc exploration of the performance of our statistical
model. Using our statistical model, we estimated NMR to be 31.5
(29.0–35.7) in 2007 and 30.5 (28.0–34.6) in 2008, which agrees
closely with the preliminary survey estimate, and, thus, suggests
that our statistical model is performing well, at least for recent
years’ trend in this African country.
In 2010, Rajaratnam et al. published NMR time series as part of
their systematic evaluation of trends and levels of child mortality
[15]. Figures S3, S4, S5, S6 present a detailed comparison of
estimates at country, regional, and global levels in the period
1990–2009, including Bland-Altman plots for each year with the
relative difference plotted as a function of the average of the two
estimates for each country. Our estimation process differs from
that of Rajaratnam et al. in a number of ways: we carried out a
country consultation, which allowed countries to review data
inputs and estimates and provide us with their feedback; (a) we
used more recent data, primarily as our estimates were finalized
2 y later, which allowed us to better predict current and recent
years’ NMRs (assuming same methods are used); (b) our focus is on
neonatal mortality levels and trends, whereas Rajaratnam et al.
focused on child mortality under five. However, from a statistical
modeling perspective, both approaches use a multilevel modeling
approach with U5MR as the main predictor of NMR, together
with country and regional information. The main differences to
our methods are that Rajaratnam et al. allowed slope coefficients
to vary by country and region, that Rajaratnam et al. made use of
their own estimated U5MR time series, and in that Rajaratnam et
al. predict NMR separately for the two sexes. Rajaratnam et al.
furthermore do a joint decomposition of the U5MR into the age
groups neonatal, postneonatal (1–11 mo), and child (12–59 mo).
This approach requires each observation in the data base to have
information on all three rates (assuming data imputation is not
carried out), which most likely explains why their data base for
NMR modeling has half the number of observations of ours.
Generally, the two sets of NMR time series are in close agreement.
At global and regional levels relative differences are for most years
on the order of 65% and 610%, respectively, which are well
inside the uncertainty range of the estimates. For most countries,
relative differences between NMR estimates are within 625% for
most years. For example, the number of countries with differences
greater than 625% are 44 for year 2009 (24%) and 34 for year
1990 (18%).
The most recent systematic evaluation of child causes of deaths
is for year 2008 [4]. Major causes of neonatal deaths globally in
2008 were estimated to be complications from preterm delivery
(29%), asphyxia (23%), and infections with sepsis and pneumonia
as the major causes contributing a combined 25% of neonatal
deaths [4]. Countries with lower NMR typically had higher
proportions of neonatal deaths caused by preterm delivery
complications and congenital anomalies [4], and those with high
mortality have around half of neonatal deaths due to infections,
which are eminently preventable or treatable [1].
Conclusion
In the absence of regular, reliable civil registration data from
92% of the world’s births, modeling is necessary for public health
Figure 7. Changes in NMRs between 1990 and 2009. The map illustrates the change in NMR between the years 1990 and 2009 for each of the
193 countries estimated for.
doi:10.1371/journal.pmed.1001080.g007
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systems and surveys improve the measurement of neonatal deaths
and also stillbirths [31], considerable uncertainty around both
these mortality rates and progress in reducing them will remain.
More investment is required to improve and establish the quality
of pregnancy outcome data especially in retrospective surveys [32].
Regular annual reporting of NMR through the UN system should
become the norm, as is the case for under-five mortality rates.
Our findings highlight inter-regional variation in progress but
also remarkable variation between countries in the same region.
More evaluation is required to understand this variation in
progress and better understanding of the underlying reasons would
be critical in accelerating progress for neighboring countries.
The relative contribution of neonatal deaths to child deaths is
expected to increase into the future. Progress in reducing neonatal
mortalityriskoverthelast20 yhasbeenslow,particularlyinregions
with the greatest risk. National governments, international organi-
zations, nongovernmental organizations, and other international
health bodies must increase investment in care at birth and the first
few weeks of life within existing health programs, adding targeted
interventions especially at the time of birth [33]. The majority of
neonatal deaths could be prevented with existing interventions
including some that can be delivered at community level with
potential to reduce neonatal deaths by one-third, such as improved
hygiene at birth, breastfeeding, and simple approaches to keeping
babies warm [6]. Maternal health programs and child health
programs are beginning to place greater emphasis on newborn
survival, but major missed opportunities remain even in existing
programs [34]—for example midwives who are not trained and
equipped for simple newborn care and neonatal resuscitation [35].
Many of the 79 million babies who died in the neonatal period since
1990 were born with little or no access to health services and in
settings with little health information to drive health system
improvement. If MDG-4 is to be achieved, and this needless loss
of life prevented, it is essential that national governments,
international agencies, and civil society increase attention to
systematically preventing and tracking neonatal deaths [9].
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Background. Every year, more than 8 million children die
before their fifth birthday. Most of these deaths occur in
developing countries and most are caused by preventable or
treatable diseases. In 2000, world leaders set a target of
reducing child mortality to one-third of its 1990 level by 2015
as Millennium Development Goal 4 (MDG4). This goal,
together with seven others, is designed to help improve
the social, economic, and health conditions in the world’s
poorest countries. In recent years, progress towards reducing
child mortality has accelerated but remains insufficient to
achieve MDG4. In particular, progress towards reducing
neonatal deaths—deaths during the first 28 days of life—has
been slow and neonatal deaths now account for a greater
proportion of global child deaths than in 1990. Currently,
nearly 41% of all deaths among children under the age of 5
years occur during the neonatal period. The major causes of
neonatal deaths are complications of preterm delivery,
breathing problems during or after delivery (birth
asphyxia), and infections of the blood (sepsis) and lungs
(pneumonia). Simple interventions such as improved
hygiene at birth and advice on breastfeeding can
substantially reduce neonatal deaths.
Why Was This Study Done? If MDG4 is to be met, more
must be done to prevent deaths among newborn babies. To
improve survival rates and to monitor the effects of public-
health interventions in this vulnerable group, accurate, up-to-
date estimates of national neonatal mortality rates (NMRs, the
number of neonatal deaths per 1,000 live births) are essential.
Although infant(under-one)andunder-five mortality rates are
estimated annually for individual countries by the United
Nations Interagency Group for Child Mortality Estimation,
annual NMR trend estimates have not been produced before.
In many developed countries, child mortality rates can be
calculateddirectly from vital civil registration data—records of
all births and deaths. But many developing countries lack vital
registration systems and child mortality has to be estimated
using data collected in household surveys such as the
Demographic and Health Surveys (a project that helps
developing countries collect data on health and population
trends). In this study, the researchers estimate annual national
NMRs and numbers of neonatal deaths for the past 20 years
using the available data.
What Did the Researchers Do and Find? The researchers
used civil registration systems, household surveys, and other
sources to compile a database of deaths among neonates
and children under 5 years old for 193 countries between
1990 and 2009. They estimated NMRs for 38 countries from
reliable vital registration data and developed a statistical
model to estimate NMRs for the remaining 155 countries (in
which 92% of global live births occurred). In 2009, 3.3 million
babies died during their first month of life compared to 4.6
million in 1990. More than half the neonatal deaths in 2009
occurred in five countries—India, Nigeria, Pakistan, China,
and the Democratic Republic of Congo. India had the largest
number of neonatal deaths throughout the study. Between
1990 and 2009, although the global NMR decreased from
33.2 to 23.9 deaths per 1,000 live births (a decrease of 28%),
NMRs increased in eight countries, five of which were in
Africa. Moreover, in Africa as a whole, the NMR only
decreased by 17.6%, from 43.6 per 1,000 live births in 1990
to 35.9 per 1,000 live births in 2009.
What Do These Findings Mean? These and other
findings suggest that neonatal mortality has declined in all
world regions since 1990 but that progress has been slowest
in the regions with high NMRs such as Africa. Although there
is considerable uncertainty around the estimates calculated
by the researchers, these findings nevertheless highlight the
slow progress in reducing the neonatal mortality risk over
the past 20 years and suggest that the relative contribution
of neonatal deaths to child deaths will increase into the
future. Thus, if MDG4 is to be achieved, it is essential that
national governments and international health bodies invest
in improved methods for the measurement of neonatal
deaths and stillbirths and increase their investment in the
provision of care at birth and during the first few weeks of
life.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001080.
N The United Nations Children’s Fund (UNICEF) works for
children’s rights, survival, development, and protection
around the world; it provides information on Millennium
Development Goal 4, and its Childinfo Web site provides
detailed statistics about child survival and health, including
a description of the United Nations Interagency Group for
Child Mortality Estimation and a link to its database, and
information on newborn care (some information in several
languages)
N The World Health Organization also has information about
the Millennium Development Goal 4, provides information
on newborn mortality, and provides the latest estimates of
child mortality
N Further information about the Millennium Development
Goals is available
N Information is also available about the Demographic and
Health Surveys
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